FDA.reportPublic FDA data

alendronic acid 70 MG Effervescent Oral Tablet

RxCUI
1248077
RxNorm name
alendronic acid 70 MG Effervescent Oral Tablet
Display name
alendronic acid 70 MG Effervescent Oral Tablet
Full name
alendronic acid 70 MG Effervescent Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:16

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BinostoALENDRONATE SODIUMRadius Health, Inc.09765234-01bc-40f7-b9bb-c167056f39092026-02-06Warnings, Adverse reactionsExact identifier
rxcui: 1248077

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
b278a11a-b8d7-49f3-9b38-29b67c4c417ealendronate sodium 70 MG Effervescent Oral Tablet [PSN] · alendronic acid 70 MG Effervescent Oral Tablet [SCD] · alendronic acid (as alendronate sodium) 70 MG Effervescent Oral Tablet [SY]323BINOSTO (alendronate sodium) effervescent tablets for oral solution These highlights do not include all the information needed to use BINOSTO ® safely and effectively. See full prescribing information for BINOSTO. BINOSTO (alendronate sodium) effervescent tablets for oral solution Initial U.S. Approval: 199520231220
ad670460-141b-e481-f713-7aed9485de8dalendronate sodium 70 MG Effervescent Oral Tablet [PSN] · alendronic acid 70 MG Effervescent Oral Tablet [SCD] · alendronic acid (as alendronate sodium) 70 MG Effervescent Oral Tablet [SY]39These highlights do not include all the information needed to use BINOSTO ® safely and effectively. See full prescribing information for BINOSTO. BINOSTO (alendronate sodium) effervescent tablets for oral solution Initial U.S. Approval: 199520181022
09765234-01bc-40f7-b9bb-c167056f3909alendronate sodium 70 MG Effervescent Oral Tablet [PSN] · alendronic acid 70 MG Effervescent Oral Tablet [SCD] · alendronic acid (as alendronate sodium) 70 MG Effervescent Oral Tablet [SY]36These highlights do not include all the information needed to use BINOSTO ® safely and effectively. See full prescribing information for BINOSTO. BINOSTO (alendronate sodium) effervescent tablets for oral solution Initial U.S. Approval: 199520260206